Recombinant methionyl granulocyte colony-stimulating factor (filgrastim): A new dimension in immunotherapy G. SchwabT. Hecht Original Article Pages: 1 - 9
A randomized study of mitoxantrone plus cytarabine versus daunomycin plus cytarabine in the treatment of previously untreated adult patients with acute nonlymphocytic leukemia S. PavlovskyJ. Gonzalez LlavenF. José de Diego Original Article Pages: 11 - 15
High expression of bcl-2 is the rule in acute lymphoblastic leukemia, except in Burkitt subtype at presentation, and is not correlated with the prognosis J. L. GalaC. VermylenP. Martiat Original Article Pages: 17 - 24
Interleukin-6 production in B-cell neoplasias and Castleman's disease: Evidence for an additional paracrine loop R. BurgerJ. WendlerM. Gramatzki Original Article Pages: 25 - 31
Hematologic aspects of end-stage renal failure P. ZachéeJ. VermylenM. A. Boogaerts Original Article Pages: 33 - 40
Role of protein kinases in antitumor drug resistance H. GrunickeJ. HofmannF. überall First Workshop of CSG-CR Pages: S1 - S6
DNA fragmentation as a consequence of cell cycle traverse in doxorubicin- and idarubicin-treated human lymphoma cells P. J. SmithC. RackstrawF. Cotter First Workshop of CSG-CR Pages: S7 - S11
Cytotoxicity of anthracyclines: Correlation with cellular uptake, intracellular distribution and DNA binding F. GieselerH. BiersackV. Nüßler First Workshop of CSG-CR Pages: S13 - S17
Drug-induced changes in the expression of MDR-associated genes: Investigations on cultured cell lines and chemotherapeutically treated leukemias V. GekelerJ. BeckD. Niethammer First Workshop of CSG-CR Pages: S19 - S24
Clinical importance of P-glycoprotein-related resistance in leukemia and myelodysplastic syndromes — first experience with their reversal V. NüsslerR. Pelka-FleischerW. Wilmanns First Workshop of CSG-CR Pages: S25 - S29
Cellular drug resistance in childhood leukemia A. J. P. VeermanG. J. L. KaspersR. Pieters First Workshop of CSG-CR Pages: S31 - S34
